Technology

Lighthouse Biosciences is Lighting the Way to Better Health with its signature technology - the NanoLantern™. The NanoLantern™ comprises immobilization of one, or more, fluorescent DNA probes that light up when the DNA of a targeted pathogen is detected. Lighthouse has developed the NanoLantern™ technology by utilizing proprietary aspects of DNA detection that were invented by the Company's founders. Leveraging its NanoLantern™ technology, Lighthouse is developing market beating in vitro diagnostic tools that can be used in clinical laboratories and hospitals for detection and differentiation of infectious agents. These tools provide a unique blend of speed, sensitivity, and specificity, combined into a highly arrayable format. The Company believes that no other diagnostic platform offers this combination of benefits.